Endothelial progenitor cell-derived exosomes can replenish the deficiency of circRNA-0018553, which is decreased expression in Ang II-treated cardiomyocytes, and then attenuate cardiac hypertrophy by targeting miR-4731. Here, AGT is linked to cardiac hypertrophy.